162 related articles for article (PubMed ID: 32100239)
1. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.
Desnoyers A; González C; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Mol Diagn Ther; 2020 Apr; 24(2):143-151. PubMed ID: 32100239
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
[TBL] [Abstract][Full Text] [Related]
3. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma.
Zhang ZY; Xu KS; Wang JS; Yang GY; Wang W; Wang JY; Niu WB; Liu EY; Mi YT; Niu J
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):61-6. PubMed ID: 17981018
[TBL] [Abstract][Full Text] [Related]
4. Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.
Ahn SB; Mohamedali A; Chan C; Fletcher J; Kwun SY; Clarke C; Dent OF; Chapuis PH; Nice E; Baker MS
PLoS One; 2014; 9(5):e97248. PubMed ID: 24821188
[TBL] [Abstract][Full Text] [Related]
5. Expression of Interleukin-6 and Integrin ανβ6 in Colon Cancer: Association with Clinical Outcomes and Prognostic Implications.
Liang B; Li L; Miao R; Wang J; Chen Y; Li Z; Zou X; Zhou M
Cancer Invest; 2019; 37(3):174-184. PubMed ID: 30982362
[TBL] [Abstract][Full Text] [Related]
6. Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.
Zhang Y; Wei L; Yu J; Li G; Zhang X; Wang A; He Y; Li H; Yin D
Oncol Rep; 2014 Nov; 32(5):1787-95. PubMed ID: 25176506
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis.
Saleh RR; Peinado P; Fuentes-Antrás J; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Front Oncol; 2019; 9():1040. PubMed ID: 31681578
[No Abstract] [Full Text] [Related]
8. Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; van de Putte G; Dong HP; Goldberg I; Amir S; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(7):599-609. PubMed ID: 14669791
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F; Qi L; Liu B; Liu J; Zhang H; Che D; Cao J; Shen J; Geng J; Bi Y; Ye L; Pan B; Yu Y
PLoS One; 2015; 10(3):e0116683. PubMed ID: 25775399
[TBL] [Abstract][Full Text] [Related]
13. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
[TBL] [Abstract][Full Text] [Related]
15. Circulating DNA and Survival in Solid Tumors.
Ocaña A; Díez-González L; García-Olmo DC; Templeton AJ; Vera-Badillo F; José Escribano M; Serrano-Heras G; Corrales-Sánchez V; Seruga B; Andrés-Pretel F; Pandiella A; Amir E
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):399-406. PubMed ID: 26604269
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; McNamara MG; Šeruga B; Vera-Badillo FE; Aneja P; Ocaña A; Leibowitz-Amit R; Sonpavde G; Knox JJ; Tran B; Tannock IF; Amir E
J Natl Cancer Inst; 2014 Jun; 106(6):dju124. PubMed ID: 24875653
[TBL] [Abstract][Full Text] [Related]
19. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
20. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
